The Chemiluminescence Immunoassay (CLIA) Analyzers Market is expected to grow from USD 5.2 billion in 2020 to USD 7.2 billion by 2026 at a CAGR of over 5.8% during the forecast period.
In 2020, North America led the market, expected to continue growing rapidly, thanks to demand for advanced analyzers and major players like Abbott Laboratories and Johnson & Johnson. Asia-Pacific's market growth is fueled by increasing chronic disease cases.